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► First known study to examine PPCPs in the South Atlantic Bight.
► Examines seasonal and regional trends of PPCP concentrations in a coastal system.
► Eleven PPCPs were quantified in WWTP influent, 9 in effluent, and 7 in surface water.
► Removal from aqueous phase in wastewater treatment is generally estimated to be >86%.
► Greater detection in winter may have been related to colder temperatures.
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This study assessed seasonal and regional trends of pharmaceuticals and personal care products (PPCPs)
detected in monthly samples from two local wastewater treatment plants (WWTPs) in Charleston, South
Carolina, USA, over the period of one year. Surface water of Charleston Harbor was also analyzed to examine
environmental distribution in an estuarine ecosystem. Of the 19 compounds examined, 11 were quantified in
wastewater influent, 9 in effluent, and 7 in surface water. Aqueous concentrations of many PPCPs were re-
duced by >86% in wastewater effluent compared with influent, though some compounds showed low
removal and greater effluent concentrations compared with influent (e.g. estrone and fluoxetine). Differ-
ences in effluent concentrations and estimated removal between facilities were likely related to variations
in the facilities' operating procedures. Surface water concentrations were generally reduced by >90% for
those chemicals found in effluent. Additionally, there were seasonal trends that indicate reduced degradation
in colder months in wastewater and surface water. To our knowledge, this is the first study examining PPCPs
in the South Atlantic Bight.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
The presence of pharmaceuticals and personal care products
(PPCPs) and their metabolites in the environment has become a
growing area of research in environmental science. PPCPs consist of
commonly used over-the-counter and prescription drugs and chemicals
found in consumer products. The entry of PPCPs into the environ-
ment can result in inadvertent exposure of non-target organisms,
resulting in a range of potential impacts. For example, wide-
spread use of antimicrobial products and prescription antibiotics
has been implicated in the selection for antibiotic-resistance in
bacteria (Chee-Sanford et al., 2001). Bioaccumulation of antimi-
crobials, hormones, and antidepressants has been shown to
occur in a variety of aquatic organisms (DeLorenzo et al., 2008;
Fair et al., 2009; Gomes et al., 2004; Nakamura et al., 2008). Ad-
ditionally, environmentally-relevant levels (e.g. 5 ng/L) of the
synthetic estrogen ethinylestradiol found in oral contraceptives
have been shown to cause reproductive failure in fish (Nash et
al., 2004) and the eventual collapse of a fish population (Kidd
et al., 2007).
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PPCPs are introduced into aquatic environments by both point-
and nonpoint-sources such as domestic wastewater treatment plant
(WWTP) effluent, among others (Daughton and Ternes, 1999). One
of the largest inputs into the environment results from the human in-
gestion and subsequent excretion of pharmaceuticals (Williams,
2005); up to 90% of a drug can be excreted in its original, active
form (Halling-Sørensen et al., 1998). The nearly universal use of
these types of products by consumers results in constant input into
not only WWTPs, but also constant, low-level input into the environ-
ment itself.
Some PPCPs may be degraded during wastewater treatment
whereas others may pass through the process largely unchanged,
remaining dissolved and becoming diluted or sorbing to solids that
settle out of the waste stream (Aga, 2008). For example, some com-
pounds such as triclocarban demonstrate high removal from the
aqueous phase of wastewater; however, it is fairly persistent in the
solid phase (Heidler et al., 2006). Additionally, the impact of degrada-
tion products must also be considered as some transformed chemicals
are potentially more mobile or persistent than their parent com-
pounds (Aga, 2008). Some PPCP metabolites that have been conjugat-
ed into less biologically active forms within the consumer's body can
become deconjugated into their active forms during wastewater
treatment or in the environment due to microbial action (Huang
and Sedlak, 2001; Ternes, 1998). Overall, the effectiveness of PPCP re-
moval can be highly variable within and between facilities due to
general operating conditions, technology used, microbial community
composition, and methods of disinfection (Khanal et al., 2006;
Radjenovic et al., 2009; Suarez et al., 2008). Because of this and the di-
versity of chemicals contained within the term “PPCP”, relatively little
can be inferred about removal and subsequent discharge of one
chemical to another, as well as chemicals from one facility to another.
Because WWTPs serve as major point-sources of PPCPs in the en-
vironment, examining the flow and distribution from facilities into
receiving environments may allow for a clearer assessment of wheth-
er sensitive ecosystems may be at risk. Estuaries are a critical link be-
tween freshwater and marine ecosystems — they serve as feeding,
spawning, and nursery grounds for a variety of economically and bio-
logically important organisms and are some of the most productive
ecosystems on the planet (Odum, 1983). In order to minimize poten-
tial negative impacts of increasing urban development in coastal
zones, monitoring these sensitive ecosystems is vital. Multiple studies
have demonstrated the presence of low concentrations of PPCPs in
freshwater environments that serve as discharge locations for treated
WWTP effluent (Boyd et al., 2003; Kim et al., 2007; Ternes et al.,
1999a); however, many works do not include discussion of PPCPs in
coastal settings. Few studies to date have examined PPCPs in saline
environments (Benotti and Brownawell, 2009; Pait et al., 2006;
Singh et al., 2010).
The objective of this study was to assess the distribution and sea-
sonal trends of 19 target PPCPs, including 11 hormones (Table 1),
withinWWTPs in Charleston, SC, USA, over the period of one year. Be-
cause these facilities discharge treated effluent into the Charleston
Harbor, surface water of the harbor was analyzed to examine envi-
ronmental distribution of PPCPs in an estuarine ecosystem of the
South Atlantic Bight.
2. Methods
2.1. Sample collection
Wastewater was sampled from two local water utilities (Charleston
Water System “CWS” and Mount Pleasant Waterworks “MPW”) in
Charleston County, SC, fromApril 2009 toMarch 2010. The CWSwaste-
water treatment plant has an average flow of 20 million gallons/day
(MGD). It utilizes primary and secondary treatmentmethods and disin-
fects effluent with sodium hypochlorite (Andy Fairey, CWS, personal
communication). The MPW facility has an average flow of 5.1 MGD
and treats wastewater similarly to CWS, but additionally utilizes an an-
oxic basin (Allan Clum, MPW, personal communication). Within each
facility, 24-hour composite samples were collected monthly in influent
and post-chlorination effluent streams.
Surface water samples were collected in the Charleston Harbor of
Charleston, SC (Fig. 1), from each of the two wastewater outfall loca-
tions (Site 2: MPW, Site 5: CWS) and four additional sites in the har-
bor (Site 1: offshore entrance to harbor, Site 3: Cooper River–Wando
River confluence, Site 4: central location, Site 6: Ashley River).
Monthly samples were collected from approximately 2 m below the
surface using a Niskin bottle during an outgoing tide within 12–
48 h after wastewater samples were collected. All wastewater and
surface water samples were held in glass bottles for transport on ice
in the dark until receipt at the laboratory. All were extracted within
24 h of collection — those not extracted immediately were stored at
4 °C in the dark.
2.2. Sample extraction
Table 1 lists the target analytes examined in this study (these were
chosen because they are products commonly used by consumers and/
or are compounds that have the potential to pose environmental risk
to non-target organisms, based on the data from the available litera-
ture). Samples were extracted according to the published EPA Meth-
od 1694 (USEPA, 2007), with slight modification. Analytes fall into
two categories identified in EPA 1694 — Group 1 (acetaminophen,
caffeine, cotinine, fluoxetine, norfluoxetine) and Group 3 (ibuprofen,
triclocarban, triclosan). Additionally, 11 natural and synthetic hor-
mones were quantified in this study; EPA Method 1694 was modified
to include these (Sapozhnikova et al., 2011). Thus, all target analytes
were monitored in the final sample extracts. The eight estrogenic hor-
mones were not monitored for the first month of the study due to
unavailability of matched labeled surrogate standards, but were
Table 1
PPCPs analyzed in this study, their monitored m/z's (Q1: parent, Q3q: product used for
quantification, Q3c: product used for confirmation), and the MRL for wastewater (WW)
and surface water (SW) samples.
Analyte Commercial use Q1/Q3q, Q3c MRL (ng/L):
WW/SW
Acetaminophen Analgesic/antipyretic 152.1/93.1, 110.1 50.00/10.00
Caffeine Stimulant 195.2/110.1, 138.1 25.00/5.00
Cotinine Metabolite of nicotine 177.1/98.1, 80.1 18.75/3.75
Diethylstilbestrol
(DES)
Synthetic nonsteroidal
estrogen
267.0/237.0, 222.0 25.00/5.00
Equilenin Steroid hormone
(estrogen)
265.0/221.0, 249.0 12.50/2.50
Equilin Steroid hormone
(estrogen)
267.0/143.0, 223.0 12.50/2.50
17α-Estradiol Steroid hormone
(estrogen)
271.1/144.9, 183.0 12.50/2.50
17β-Estradiol (E2) Steroid hormone
(estrogen)
271.1/144.9, 183.0 5.00/1.00
Estriol (E3) Steroid hormone
(estrogen)
287.0/171.0, 145.0 5.00/1.00
Estrone (E1) Steroid hormone
(estrogen)
269.0/145.0, 159.0 5.00/1.00
17α-Ethinylestradiol
(EE2)
Synthetic steroidal
estrogen
295.0/145.0, 159.0 12.50/2.50
Fluoxetine Antidepressant 310.1/44.2, 148.2 18.75/3.75
Ibuprofen NSAID 205.0/158.9, 160.9 25.00/5.00
Norfluoxetine Metabolite of fluoxetine 296.2/134.1, 30.2 18.75/3.75
Norgestrel Synthetic progestogen 313.0/109.0, 245.0 5.00/1.00
Progesterone Steroid hormone
(progestogen)
315.0/109.0, 97.0 25.00/5.00
Testosterone Steroid hormone
(androgen)
289.0/97.0, 109.0 5.00/1.00
Triclocarban Antimicrobial 312.9/126.0, 159.8 12.50/2.50
Triclosan Antimicrobial 286.9/35.0, – 50.00/10.00
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subsequently monitored for the remaining 11 months. Method preci-
sion was initially verified using polished seawater and prepared syn-
thetic effluent (Sapozhnikova et al., 2011).
Only PPCPs dissolved in the aqueous phase were measured in this
study; therefore wastewater samples underwent vacuum filtration
(1 μm Whatman Glass Microfibre Filters). Initial method develop-
ment indicated that volumes of 100 mL for influent and 200–
250 mL for effluent were sufficient for use in SPE procedures. Samples
were adjusted to pH 2.00±0.05 using hydrochloric acid, spiked with
matched labeled surrogate standards, stabilized with Na4EDTA·2H2O,
and underwent solid phase extraction (SPE) using Waters Oasis HLB
(1 g, 20 cm3/1 g LP, 60 μm) cartridges. Next, cartridges were dried
for 30 min, then analytes were eluted (according to EPA 1694) and
extracts were evaporated to dryness. Methanol (0.5 mL) was used
for reconstitution and extracts were filter centrifuged (0.45 μm
nylon filter). After transfer to amber autosampler vials, HPLC water
(0.6 mL) was added along with the labeled injection internal stan-
dards. Atrazine-d5was used as an injection internal standard for anal-
ysis of analytes in Group 1 as well as for norgestrel, progesterone, and
testosterone. 13C6-2,4,5-Trichlorophenoxyacetic acid was used as an
injection internal standard for analytes in Group 3 and phenacetin
(ethoxy-1-13C) served as an injection internal standard for the
eight estrogenic hormones.
Surface water samples (1 L) underwent the same extraction pro-
cedures as wastewater, except 150 mL reservoir tubes containing
10 μm polyethylene frits were attached to HLB cartridges during
SPE loading for filtering particulate matter. A reagent blank using
HPLC water, sample replicate, and matrix spike were extracted with
each sample batch for quality assurance/quality control.
2.3. Sample analysis
An Agilent 1100 HPLC system (Agilent Technologies Inc.) coupled
with an API-4000 triple quadrupole mass spectrometer (Applied
Biosystems/MDS Sciex) was used with an Xterra MS C18 column
(Waters Corp., 3.5 μm, 2.1×100 mm) in a 40 °C column oven to
separate analytes using a binary gradient (USEPA, 2007). Analytes
were detected using a multiple reaction monitoring mode. The
autosampler tray temperature was set at 4 °C for all samples. For
analysis of Group 1 (ESI+) and Group 3 (ESI−) PPCPs, HPLC proce-
dures followed steps outlined in EPA Method 1694; procedures for
analysis of hormones are described in Sapozhnikova et al. (2011).
Progesterone, testosterone, and norgestrel were added to the acquisi-
tion method for Group 1 analytes. The remaining estrogens were an-
alyzed using a reverse phase Phenomenex Gemini-NX C18 column
(3 μm, 50×2.0 mm) fitted with a guard column (Phenomenex
Gemini-NX C18, 4×2.0 mm) at 30 °C.
Two parent-product transition mass-to-charge transitions (m/z's)
were monitored for most analytes (Table 1) and ratios of product
transitions were calculated to ensure correct identification. Calibra-
tion curves used for quantification (minimum of 5 levels) were linear
for all compounds with r2>0.98 for Group 1 and Group 3 analytes
and r2>0.99 for hormones. A continuous calibration verification sam-
ple was run every six samples within each monthly batch of samples.
2.4. Statistical analyses
Method reporting limits (MRLs; Table 1), were calculated according
to Vanderford et al. (2003). Data were analyzed using R 2.10.1 and SAS
9.1 with α=0.05 for all statistical tests. Assumptions of parametric
analyses were tested using a Shapiro–Wilk test and Bartlett's test; ap-
propriate transformations were applied if needed (as described in
each of the following sections).
2.4.1. Site differences
Detection probabilities of analytes were calculated (PROC FREQ in
SAS). A generalized linear model (logistic regression with a binomial
distribution) was fit to the data by maximum likelihood estimation of
parameters and using a logit link function in SAS in order to examine
the probability of detects vs. nondetects. For wastewater samples, aver-
age annual concentrations for PPCPs detected above MRLs were
compared using two sample t-tests. Data that did notmeet the assump-
tion of normality after logarithmic transformation were analyzed using
an exactWilcoxonMann–Whitney rank sum test. (More information on
statistical tests used for these analyses is described in Appendix A.) For
surfacewater samples, only caffeine concentrationswere examined due
Fig. 1. Sampling locations for the monitoring study in the Charleston Harbor and Charleston, SC, USA. WWTP locations (Plum Island of CWS, Rifle Range Road of MPW) are indicated by
circles; surface water sample collection sites (6 total) are designated by squares. Surface water sample sites located at discharge locations for each WWTP are indicated by arrows.
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to its high detection frequency. Analysis of variance (ANOVA) of the z
score transformed data was used to determine if concentrations varied
by site.
2.4.2. Wastewater removal efficiencies
Estimated percentages of analyte removal in the aqueous phase
during wastewater treatment were calculated for both facilities as
([influent]−[effluent])÷[influent]×100. Non-detects in effluent sam-
ples were assumed to have a concentration at the MRL (vs. 0 ng/L, for
example) for each respective analyte, resulting in a conservative esti-
mate of minimum removal percentage. To resolve whether statistical
differences in removal existed betweenWWTPs, analysis of covariance
(ANCOVA, Type III SS) was used to compare slopes of influent–effluent
regressions for compounds where detection was 100% in both influent
and effluent samples. Only those chemicals with >60.0% detection in
wastewater were individually analyzed after using Helsel's robust
method for uncensoring data (Helsel, 1990, 2005) prior to the
ANCOVA analyses. (Chemicals with lower detection frequency were
not analyzed.)
2.4.3. Seasonality
Spring (March 2010, April and May 2009), summer (June, July, Au-
gust 2009), fall (September, October, November 2009), andwinter (De-
cember 2009, January and February 2010) sampling months were
compared to examine seasonal trends in detection/concentration. De-
tection probabilities of analytes were calculated and statistically ana-
lyzed as described previously for site differences. Concentrations of
PPCPs in wastewater were examined in relation to season using
ANOVA with a Tukey HSD test for pairwise comparisons. WWTPs
were examined separately; only compounds with 100% detection in in-
fluent and >91.0% detection in effluent were analyzed. Logarithmic
transformations were applied to the analyses of acetaminophen, caf-
feine, and cotinine inwastewater tomeet the assumptions for paramet-
ric tests. Due to no/limited detection in surface water for PPCPs in some
months, only the three most frequently detected compounds in surface
waters (caffeine, cotinine, acetaminophen) were analyzed for seasonal
trends.
3. Results and discussion
3.1. Wastewater samples
The ranges of PPCP concentrations detected in this study are com-
parable to concentrations reported in other studies (Agüera et al.,
2003; Trenholm et al., 2006; Vanderford and Snyder, 2006; Zhou et
al., 2010). Eleven of the target compounds were detected above
MRLs in influent samples of bothWWTPs (Table 2). For both facilities,
acetaminophen, caffeine, and ibuprofen were detected in the first,
second, and third largest concentrations, respectively. This is not sur-
prising, given that these are found in numerous over-the-counter and
prescription medications. Additionally, caffeine is present in a wide
assortment of consumer items. The 1998–1999 Slone Survey reported
acetaminophen as the first and ibuprofen as the second most com-
monly used drugs in American households. Caffeine ranked ninth
based on OTC/prescription drug use only; food/beverage content
was not considered (Kaufman et al., 2002).
In this study, triclosan and triclocarban were the fourth and fifth
ranked PPCPs detected in wastewater based on influent concentra-
tions. Both are antimicrobial compounds found in a variety of
consumer products including soaps, toothpastes, etc. Although pro-
duction volume numbers for triclosan in the USA are difficult to dis-
cern, widespread use and estimated production in the European
Union (10–1000 t/year, Dye et al., 2007) indicate that the numbers
are likely high in the USA as well. Triclocarban was reported as a
Moderate Production Volume compound in 2005 with less than
500,000 lb of import/production in the USA (USEPA, 2009). Cotinine,
a human metabolite of nicotine, followed as the sixth highest PPCP
detected in influent.
Nine compounds were detected above MRLs in effluent samples of
CWS (Table 2). Eight of these were also detected in MPW effluent sam-
ples; estronewas not detected. Caffeine and ibuprofen ranked as the top
two PPCPs detected, followed by triclocarban>acetaminophen>triclo-
san. Acetaminophen, triclosan, and triclocarban most likely differed in
ranking between influent and effluent due to increased removal during
treatment (Fig. 2). It has been noted in other studies that triclocarban is
more persistent throughout wastewater treatment than triclosan
(Heidler and Halden, 2007; Heidler et al., 2006).
Table 2
Detection frequency (%, in bold) and mean annual concentration (ng/L, ±standard deviation) of PPCPs detected above MRLs in samples for each WWTP (I: Influent, E: Effluent; *
indicates significant differences between WWTPs), and surface water (na: not detected/unable to calculate).
Analyte WWTP Surface water
Site CWS MPW
Acetaminophen I (100) 99 498±29 368 (100) 113 281±38 596 (22.2) 15±5
E (100) 354±752 (100) 152±87
Caffeine I * (100) 66 400±15 447 (100) 82 882±16 359 (98.6) 19±11
E * (100) 924±865 (91.6) 207±498
Cotinine I (100) 1 461±437 (100) 1 598±363 (33.3) 6±2
E * (100) 49±44 (100) 72±32
Estriol I * (100) 175±48 (100) 217±26 (0) na
E (0) na (0) na
Estrone I * (100) 31±7 (100) 40±12 (0) na
E * (81.8) 38±24 (0) na
Fluoxetine I (100) 61±22 (100) 75±24 (0) na
E (100) 60±17 (100) 56±24
Ibuprofen I (100) 24 317±8 797 (100) 24 033±7 713 (4.2) 8±3
E * (66.7) 928±779 (8.3) 2 600±na
Norfluoxetine I * (100) 45±13 (100) 58±15 (2.8) 7±3
E (41.7) 20±1 (8.3) 26±na
Testosterone I (100) 42±21 (100) 46±17 (0) na
E (0) na (0) na
Triclocarban I (100) 4 566±3 520 (100) 4 644±2 369 (6.9) 3±1
E * (100) 617±273 (100) 311±359
Triclosan I (100) 5 341±2 878 (100) 6 817±3 348 (6.9) 20±12
E (75.0) 129±66 (33.3) 163±166
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3.1.1. Site differences
For influent, annual average concentrations of caffeine (p=0.019),
estriol (p=0.018), estrone (p=0.048), and norfluoxetine (p=0.022)
were significantly higher inMPWcomparedwith CWS (Table 2). For ef-
fluent, cotinine was detected in significantly higher concentrations in
MPW vs. CWS (p=0.025). Conversely, caffeine (p=0.004), ibuprofen
(p=0.009), and triclocarban (p=0.004) concentrations were signifi-
cantly higher in CWS effluent, aswell as estrone (pb0.001, due to node-
tection in MPW). Overall, the probability of detecting pooled target
analytes in effluent was higher in CWS (70%) vs. MPW (50%, X2=
10.65, df=1, p=0.001; based on PROC FREQ analysis). In addition,
the probability of detection was higher for effluent in CWS (81.8%) vs.
MPW (57.6%) specifically for winter samples (seasonal trends further
explained in the next section). Differences in detection and concentra-
tions of PPCPs in effluent samples may be related to effluent composi-
tion (i.e. particulate matter), slight differences in the treatment
process of MPW (anoxic basin) vs. CWS, microbial community compo-
sition in the WWTPs, and perhaps the size of the WWTPs.
3.1.2. Removal efficiencies
Overall, estimated percent removal of most compounds was high
in both facilities (Fig. 2), and variable removal among individual
compounds is most likely reflective of the variable nature of the
chemicals' properties. Statistical analyses of acetaminophen, cotinine,
fluoxetine, and triclocarban, and after uncensoring non-detect values
in the data, caffeine, ibuprofen, norfluoxetine, and triclosan, indicated
no significant difference in removal from CWS vs. MPW. Although
effluent concentrations displayed significant differences between
facilities for some of these compounds, these were highly variable.
Thus, estimated removal did not statistically differ between plants.
Estronewas the only compound that demonstrated a significant dif-
ference in removal between facilities. After uncensoring non-detect
values for estrone, removal in MPW was higher than CWS (Figs. 2, 3,
p=0.022). It is possible that aqueous removal was higher for MPW
vs. CWS becauseMPW's facility utilizes an anoxic basin as an additional
step in the wastewater treatment process; both anoxic and anaerobic
conditions have been shown to accelerate the removal of estrone, estra-
diol, and ethinylestradiol (Joss et al., 2004; Kreuzinger et al., 2004). A
review by de Mes et al. (2005) suggests that removal of estrogens
during denitrification in anoxic conditions is due largely to adsorp-
tion as opposed to conjugation. Thus, the additional treatment step
in MPW may have allowed for additional solid sorption, resulting
in lower concentrations in the aqueous phase. The solid fractions of
wastewater samples were not examined in this study, although
monitoring the concentrations of these compounds in both the
aqueous and solid matrices, as well as at different steps of the treat-
ment process, would more precisely reveal distribution of PPCPs in
these WWTPs.
On almost half of the sampling dates, estrone concentrations in
CWS effluent exceeded influent concentrations (as indicated by neg-
ative percentages for estimated removal in Fig. 2; see also Fig. 3 and
Appendix B); high effluent concentrations vs. low influent concentra-
tions may occur due to transformation and/or deconjugation during
treatment. For example, 17β-estradiol can be broken down into
estrone by bacteria present in activated sludge of WWTPs, bacteria
in the surface waters, and via photolysis (Khanal et al., 2006).
Fig. 2. Box and whisker plots showing estimated percentage removal of analytes during wastewater treatment in each WWTP. Note: non-detects in effluent were treated as if con-
centrations were at MRL levels, resulting in a conservative, minimum estimate for removal.
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Biodegradation results in the removal of 17β-estradiol, but conver-
sion of estrone into nonestrogenic products has been suggested as
the rate-limiting step in estrogen biodegradation (Yu et al., 2006).
In addition, estrone is largely excreted from the human body as estri-
ol or in a conjugated form. It has been shown that there is potential
for estrogen conjugates to be cleaved by microorganisms in wastewa-
ter sludge, resulting in an increase of the deconjugated form (Ternes
et al., 1999b). This does not occur only with estrogens; conjugates
of other organic compounds may also be cleaved resulting in higher
effluent concentrations (Ternes, 1998). This may explain why larger
concentrations of fluoxetine were also detected in effluent vs. influent
on numerous sampling dates in both facilities (Fig. 2). After an oral
dose in a healthy individual, it is estimated that 2.5% of the fluoxetine
dose is excreted as the parent compound, 5.2% as the fluoxetine
glucuronide conjugate, 10% as norfluoxetine, 9.5% as the norfluoxetine
glucuronide conjugate, and the remainder as unidentified metabolites
(Medscape and AHFS, 2010). Analysis of PPCPs including their conjugates
would elucidatewhether the deconjugation pathway inwastewater is re-
sponsible for increased effluent concentrations within local facilities.
3.1.3. Seasonality
Probability of detecting pooled PPCPs in effluent samples collected
in winter was significantly higher in CWS (81.8%) vs. MPW (57.6%,
X2=4.38, df=1, p=0.036; based on PROC FREQ analysis). No trends
were apparent for other seasons when comparing CWS vs. MPW. Ad-
ditionally there was a significantly higher probability of detection
within CWS effluent for winter samples (81.8%) compared with sum-
mer samples (57.6%, X2=4.38, df=1, p=0.036) for pooled com-
pounds. When analyzing frequency of detection for compounds on
an individual basis, no significant seasonal trends were noted in influ-
ent or effluent; however, February 2010 was the only month where
ibuprofen (2600 ng/L) and norfluoxetine (26 ng/L) were detected in
MPW effluent (Appendix B). Acetaminophen, cotinine, and triclosan
were detected in the highest concentrations for CWS effluent in Feb-
ruary with estimated removal percentage being lowest for this month
for acetaminophen (97.6%) and cotinine (85.3%) compared with other
months (>99.6%, >94.9%, respectively). Caffeine, triclocarban, and
triclosan were detected in the highest concentrations for MPW efflu-
ent samples in February, which also corresponds to the lowest esti-
mated removal percentage compared with all other months of the
study (caffeine: 98.3% vs. >99.8% other months; triclocarban: 82.0%
vs. >84.7%; triclosan 96.2% vs. >97.7%). Totalized final effluent flow
rates in the wastewater facilities in winter were higher than other sea-
sons in both facilities; therefore, elevated detection does not appear to
be caused by an increased concentration factor of the analytes in sam-
ples. Generally, high flow may have led to a shorter residence time of
the sludge during the treatment process in winter, possibly resulting
in lower removal of compounds. Corresponding influent concentrations
were not elevated in February, suggesting that the relatively high efflu-
ent concentrations of these samples were perhaps a result of decreased
removal during treatment and not increased input of PPCPs.
Reduced sunlight in winter months may have also resulted in
reduced photodegradation; however, due to the high turbidity of
wastewater and the depth of treatment tanks, photodegradation like-
ly played a minimal role, if any. Upon examination of the wastewater
quality data for winter, water temperature on the February sampling
date was the lowest recorded for the study (CWS: 16.4 °C, MPW:
16.6 °C; maximum temperatures were ~28 °C in summer). Addition-
ally, the total suspended solids and measured oxygen demands of
both facilities' effluents were highest for the February sampling date
compared with other months, indicating that lower temperatures in
February likely reduced microbial activity of the activated sludge pro-
cess, thus reducing biodegradation of the aforementioned com-
pounds during treatment. Vieno et al. (2005) found a similar trend
where increased concentrations of PPCPs in WWTP effluent correlat-
ed with the coldest month of the year; increased effluent concentra-
tions were attributed to low temperatures reducing biodegradation
during the treatment process.
Based on concentration, six PPCPs showed seasonal trends in in-
fluent and two demonstrated trends in effluent (Table 3). Estriol
and estrone did not demonstrate significant differences by season in
CWS influent, but did in MPW influent where concentrations were
higher in the summer compared with spring and winter samples. Ef-
fluent concentrations could not be statistically analyzed for these
compounds due to low detection frequency.
3.2. Surface water samples
Only seven PPCPs were detected in local surface waters (Table 2),
with caffeine, cotinine, and acetaminophen being detected themost fre-
quently (98.6%, 33.3%, 22.2%, respectively). This is in agreement with a
nationwide USGS study (Kolpin et al., 2002), which detected these
three compounds in the highest frequencies of its target analyte list as
well (61.9%, 38.1%, 23.8%, respectively). This is not surprising, given
the near universal use of these chemicals (or in the case of cotinine,
its parent compound). The three chemicals were also detected in all in-
fluent samples in high concentrations and in almost every effluent sam-
ple with mean concentrations of caffeine>acetaminophen>cotinine
(Table 2). Surface water mean and median concentrations also demon-
strated caffeine>acetaminophen>cotinine (Table 2), which may be a
reflection of WWTP effluent most likely being a major point-source
input of these compounds into local surfacewaters, although these con-
centrations were generally reduced by >90% compared to effluent
concentrations.
The majority of studies on PPCPs in surface waters have examined
freshwater environments; however, only a few studies have examined
distribution of these compounds in marine or estuarine locations
(Benotti and Brownawell, 2007; Pait et al., 2006; Singh et al., 2010).
Concentrations of compounds detected in the Charleston Harbor are
largely within/below those reported in other studies examining fresh
and coastal waters (Kolpin et al., 2002; Pait et al., 2006; Vethaak et al.,
2002). Interestingly, some compounds such as fluoxetine were not
detected above MRLs in surface waters in this study, though they have
been reported in multiple investigations examining PPCPs in other re-
gions of the USA. Additionally, we detected norfluoxetine in two surface
water samples (Site 1: 9 ng/L and Site 6: 4 ng/L, October 2009, Appen-
dix B). Norfluoxetine has been detected in small, effluent-dominated
Fig. 3. Mean concentrations (ng/L) of estrone in effluent compared with influent for
CWS and MPW. Solid lines represent removal trends for each facility; the dashed line
represents the theoretical trend line for 0% removal.
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streams from 1.3 ng/L±25% RSD (Vanderford and Snyder, 2006) to
13.6 ng/L (Schultz et al., 2010). Only rarely has norfluoxetine been
reported in surface waters that are not effluent-dominated, and if so,
in low concentrations: 2.88 ng/L (Conley et al., 2008). Further investiga-
tion intowhether abiotic and/or biotic degradation of fluoxetinemay be
occurring in local surface waters is warranted because, 1.) there was a
lack of detection of fluoxetine above MRL and limited detection of
norfluoxetine in surface waters, and 2.) there were larger overall con-
centrations of fluoxetine compared with norfluoxetine detected in ef-
fluent (Table 2).
3.2.1. Site differences
When comparing sites in the Charleston Harbor (Fig. 1), there was
a larger overall probability of detecting PPCPs (pooled compounds) at
Site 6 (34.5%) compared with Site 4 (19.1%, p=0.025). When exam-
ining compounds individually, cotinine revealed significantly higher
probability of detection at Site 6 (58.3%) compared with Site 5 (16.
7%, p=0.045), though the cause for this is unclear (Table 4). No
other analytes detected in surface waters demonstrated statistically
significant higher detection frequencies at Site 6 vs. other sites upon
individual examination (Table 4).
Caffeine was the only compound for which concentrations were
analyzed by site in surface water due to its high detection frequency.
Concentrations were significantly higher at Site 6 compared with
Sites 4 and 2 (Table 4). Concentrations were also significantly higher
at Site 5 compared with Site 2 (both WWTP discharge sites in
Charleston Harbor). This latter result agrees with wastewater sam-
ples: caffeine was detected in significantly higher concentrations in
CWS effluent vs. MPW effluent.
One potential factor of increased detection of cotinine and
larger concentrations of caffeine at Site 6 is that the Sites 3 and
6 are located at river inputs into the Charleston Harbor. Up-
stream locations along the rivers are developed, thus those sites
may be impacted by upstream point and nonpoint-sources of
PPCPs. However, the few site differences overall reflect the fact
that the Charleston Harbor is a partially-mixed estuarine system,
likely due to the large tidal flow within the region (Althausen
and Kjerfve, 1992).
3.2.2. Seasonality
Only acetaminophen demonstrated significant seasonal trends in
surface water. Its probability of detection in winter samples (55. 6%)
was significantly higher than all other seasons: spring (11.1%, p=
0.010), summer (16. 7%, p=0.020), and fall (5. 6%, p=0.007).
When comparing acetaminophen concentrations by season, there
were no significant relationships. In WWTP effluent, concentrations of
acetaminophen were not significantly related to season; thus, higher
frequency of detection in winter surface water samples appears to be
unrelated towastewater concentrations. However, as stated previously,
all compounds (pooled)weremore frequently detected in CWSeffluent
in winter samples compared with summer samples. In addition, two of
the three detections of ibuprofen aboveMRL in surface waters occurred
in February 2010 (Appendix B), which is interesting given that the only
detection of ibuprofen in MPW effluent also occurred in this same
month. A study examining beta-blockers and antiepileptic compounds
in WWTPs and surface waters found that mass flow loadings of com-
pounds downstream of the WWTPs were highest in winter (Daneshvar
et al., 2010). Researchers also found that the highest loss of compounds
in surface waters coincided with the highest surface water temperatures
and chlorophyll amassflows. The seasonal trendof increased detection in
surfacewater in this studymay be linked to increased detection inwinter
wastewater effluent samples. Skadsen et al. (2004) also found that PPCP
concentrations in surface waters were highest in February samples com-
pared with other months, resulting from high effluent concentrations in
winter. Cold temperatures likely act uponwastewater and surface waters
in a similar fashion, i.e. less light and colder temperatures in winter
months could reduce photodegradation, depress bacterial and planktonic
activity, and thus, alter biodegradation of compounds.
4. Conclusions
This study establishes a baseline of the presence, quantity, and spatial/
temporal distribution of PPCPs in wastewater and coastal surface waters
of the South Atlantic Bight. Acetaminophen, caffeine, and ibuprofenwere
the three PPCPs detected most often in influent and effluent of both
wastewater facilities based on concentration, whereas caffeine, cotinine,
and acetaminophen were most frequently detected in surface water.
Low estimated removal percentage and larger effluent concentrations
of estrone and fluoxetine in comparison to influent may have been a re-
sult of deconjugation by bacteria in wastewater sludge, though further
examination iswarranted. Because our study only examined the aqueous
phase of wastewater, we cannot infer whether removal in wastewater
occurred via degradation of PPCPs or via sorption to particulate matter.
However, because effluent samples contained very little, if any, filtered
Table 3
Pairwise comparisons of mean seasonal PPCP concentrations (±standard deviation) in wastewater grouped byWWTP and Site (I: Influent, E: Effluent). Only statistically significant
comparisons are shown.
Analyte WWTP Site Mean concentration (ng/L) p-value
Spring Summer Fall Winter
Acetaminophen CWS I 62973±7673 133667±11060 0.003
104085±10762 62973±7673 0.028
MPW I 69423±9705 143000±26514 0.031
Caffeine CWS I 48199±3976 79967±5208 0.028
E 331±368 1868±402 0.038
81±33 1868±402 0.007
81±33 1417±723 0.014
Cotinine CWS I 1234±258 2051±53 0.023
2051±53 1046±117 0.005
MPW I 1397±124 2131±271 0.005
1337±71 2131±271 0.003
2131±271 1526±181 0.017
Estriol MPW I 191±4 243±20 0.032
243±20 196±15 0.031
Estrone MPW I 28±3 52±12 0.038
52±12 32±4 0.050
Fluoxetine CWS I 33±8 81±12 0.016
E 53±6 82±7 0.014
43±4 82±7 0.002
MPW I 55±14 101±10 0.045
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particulatematter,we believe that our study accurately depicts the trans-
port of PPCPs from effluent into local surface waters. Overall, varying pa-
rameters that alter physical properties of the waste stream (i.e. pH,
suspended solids, etc.), as well as the use of additional treatment steps
such as an anoxic basin, are likely to increase PPCP removal during do-
mestic wastewater treatment.
Some of the highest PPCP concentrations in effluent samples were
quantified on the coldest sampling date, indicating that lower tem-
peratures may have reduced treatment efficiency. Additionally, acet-
aminophen was detected at a higher frequency in winter surface
water samples, perhaps due to inhibition of abiotic/biotic degrada-
tion. Therefore, analyses of contaminants that include seasonal trends
may indicate at what periods sensitive ecosystems may be at greater
risk for exposure.
Additional research into the fate of PPCPs in coastal environments
may shed light on how properties specific to these environments may
play a role in future risk assessment. Not only dilution and tidal mixing,
but also differences in physical properties (salinity, pH, etc.) must be
taken into account when examining coastal vs. freshwater recipients.
The present study indicates that WWTP effluent is most likely a (if not
the) major point-source input of PPCPs into Charleston Harbor. Howev-
er, local surface waters appear to be relatively well-mixed due to the
large tidal flow and measured environmental concentrations of PPCPs
in this study indicate that there may be little to no risk for acute toxicity
to non-target organisms (reviewed in Farré et al., 2008), though further
examination into low-level, chronic exposure is warranted. In conclu-
sion, it is important to consider the type of recipient environment and
temporal variation of environmental conditions and inputs, along
with potential impacts on organisms, to more accurately assess poten-
tial risks of anthropogenic substances. Thiswill allow for amore respon-
sible approach for the planning andmanagement of urbanization in our
coastal regions.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.scitotenv.2012.07.076.
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